Stay updated on MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:36:19.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior notice about government funding and operating status (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:28:20.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice added about a lapse in government funding and NIH Clinical Center status, with links to cc.nih.gov and opm.gov, and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:51:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary display and updated QC/version labels to 'Last Update Submitted that Met QC Criteria' with revision v3.4.0; removed the older 'Last Update Submitted that met QC Criteria' phrasing, removed the 'No FEAR Act data' note, and dropped the previous v3.3.4 reference.
    Difference
    0.2%
    Check dated 2026-01-28T04:20:55.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is displayed, replacing v3.3.3. There are no visible changes to the study content or core details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:54:11.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A dedicated Locations section and listed sites (Kansas, Pennsylvania, Texas, Washington) were added, reorganizing location information for the study.
    Difference
    0.5%
    Check dated 2025-12-23T21:24:37.000Z thumbnail image

Stay in the know with updates to MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.